Clinical Trial

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

Name: Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer — clinical trial record (NCT04614103)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung cancer

Protocol Amendment History 1 change

notable Trial sites reduced: 91 -> 71 locations 2026-06-27

Trial Details

NCT Number	NCT04614103
Lead Sponsor	Iovance Biotherapeutics, Inc.
Conditions	Metastatic Non Small Cell Lung Cancer
Enrollment	170 participants
Start Date	2021-05-07
Primary Completion	2030-12 (estimated)
Study Completion	2031-12 (estimated)
Updated on ClinicalTrials.gov	2026-06-26